Brief: EDAP Announces Positive Results From Phase 2 Study For Therapeutic High-Intensity Focused Ultrasound

Edap Tms SA

31/01/2023 13:44

Jan 31 (Reuters) - Edap Tms SA  EDAP.O :
    * EDAP ANNOUNCES POSITIVE RESULTS FROM PHASE 2 STUDY
EVALUATING
THERAPEUTIC HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) FOR THE
TREATMENT OF RECTAL ENDOMETRIOSIS
    * EDAP TMS SA - FOCAL ONE HIFU TREATMENT RESULTED IN
SIGNIFICANT
IMPROVEMENTS IN ENDOMETRIOSIS SYMPTOMS AND QUALITY OF LIFE
    * EDAP TMS SA - POSITIVE SAFETY PROFILE WITH 96.7% OF
PATIENTS
WITH NO OR NON-SIGNIFICANT ADVERSE EVENTS
    * EDAP TMS SA - INTENDS TO INITIATE RANDOMIZED,
DOUBLE-BLIND,
SHAM-CONTROLLED STUDY IN 2Q 2023

Source text for Eikon:  ID:nGNX7J5phx 
Further company coverage:  EDAP.O 
 ((Reuters.Briefs@thomsonreuters.com;))